发布时间: 2026 - 08 - 07
Recently, the [FirstNewVoice] 2026 Q2 China's Most Active Institutions Series List was grandly released. Efung Capital was honored with the Top 30 Most Active Venture Capital Institutions in China for Q2 2026 and the Top 10 Most Active Investment Institutions in Healthcare.In the second quarter of 2026, China's equity investment market accelerated its differentiation amid structural recovery, with investment logic, valuation systems, and exit pathways undergoing deeper-level restructuring. According to FirstNewVoice's continuous tracking research over 22 consecutive ...
浏览次数:1
发布时间: 2026 - 08 - 06
On August 5, 2026, the National Medical Products Administration (NMPA) issued an announcement officially approving the market launch applications for the "Cardiac Pulsed Field Ablation Generator" and the "Single-Use Cardiac Pulsed Field Ablation Catheter," independently developed by Northchip Medical, a subsidiary of Shenzhen Northchip Life Technology Co., Ltd. ("Northchip Life"), under the trade name LotosPFA®. This marks the official entry of PFA into a new era of "routine local anesthesia."The system is the world's first pulsed field ablation...
浏览次数:2
发布时间: 2026 - 08 - 01
August 1, 2026The 99th Anniversary of the Founding of the Chinese People's Liberation ArmyOn this day, when military flags fly high and glory shines bright, EFUNG Capital extends its highest respect to all servicemen and women who have once donned military uniforms and defended our homeland, as well as to their families."A strong country must have a strong military, and only a strong military can ensure national security." Having weathered nearly a century of trials, the People's Army has advanced under the banner of the Party, forging an unbreakable iron bastion. For an inve...
浏览次数:3
发布时间: 2026 - 08 - 01
Recently, Rongzhong officially released its 2025-2026 Annual Industry Investment Rankings. EFUNG Capital was honored as one of the "Best Investment Institutions in China's Healthcare Sector 2025-2026," and CEO Zhu Pai was named one of the "Best Investment Figures in China's Healthcare Sector 2025-2026."The 2026 Government Work Report, for the first time, places the biopharmaceutical industry on par with integrated circuits, aerospace, and low-altitude economy, explicitly designating it as an "emerging pillar industry." This is not merely an iterative updat...
浏览次数:3
119页次1/30首页PREV12345678910...NEXTlast page
Address: 505 China Resources Building, 2666 Keyuan South Road, Nanshan District, Shenzhen
TEL:0755-8831-6141
E-mail:info@efungcapital.com
Copyright ©2018 - 2021 Shenzhen Efung Investment Management Co. Ltd.
Rhino Cloud provides enterprise cloud services
犀牛云提供云计算服务